Differential Fungicidal Activities of Amphotericin B and Voriconazole against Aspergillus Species Determined by Microbroth Methodology
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Antifungal agents may differ in their fungicidal activities against Aspergillus spp. In order to compare the fungicidal activities of voriconazole and amphotericin B against 40 isolates of Aspergillus fumigatus, A. flavus, and A. terreus, we developed a new microbroth colorimetric method for assessing fungicidal activities and determining minimal fungicidal concentrations (MFCs). This methodology follows the antifungal susceptibility testing reference method M-38A for MIC determination. After drug removal and addition of fresh medium, growth of viable conidia adhering to the bottoms of the microtitration wells was assessed by a colorimetric assay of metabolic activity after 24 h of incubation. The new method was faster (six times), reproducible (92 to 97%), and in agreement with culture-based MFCs (91 to 100%). Differential fungicidal activities of voriconazole and amphotericin B were found among the three Aspergillus species, with A. fumigatus and A. flavus having the lowest (1 and 2 mg/liter, respectively) and A. terreus the highest (>16 mg/liter) median amphotericin B MFCs; A. flavus had a lower median voriconazole MFC (4 mg/liter) than the other species (>8 mg/liter; P < 0.05). Amphotericin B was fungicidal (MFC/MIC </= 4) against all A. fumigatus and A. flavus isolates but no A. terreus isolates, whereas voriconazole was fungicidal against 82% of A. flavus isolates and fungistatic (MFC/MIC > 4) against 94% of A. fumigatus and 84% of A. terreus isolates. The new methodology revealed a concentration-dependent sigmoid pattern of fungicidal effects, indicating that fungicidal activity is not an all-or-nothing phenomenon and that some degree of fungicidal action can be found even for agents considered fungistatic based on the MFC/MIC ratio.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Consequently, the ratio of MFC to MIC in the presence of 1 μM PIT was 4 (Figure 5A), which aligns with the established definition of fungicidal activity (MFC/MIC ≤ 4) [48,49].”
From Pitavastatin Calcium Confers Fungicidal Properties to Fluconazole by Inhibiting Ubiquinone Biosynthesis and Generating Reactive Oxygen Species (2024) · cites this paper as [49]
In the citing paper
“A main advantage of AMB as an anti-A. fumigatus drug is the absence of resistance emergence, due in part to its cidal activity (617).”
From Aspergillus fumigatus and Aspergillosis in 2019 (2019) · cites this paper as [617]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Motulsky, H. J., & Christopoulos, A. (2004) · Cited by 1,972
Rex, J. H., & Clinical (2008) · Clinical and Laboratory Standards Institute eBooks · Cited by 1,573
Invasive Aspergillosis Disease Spectrum, Treatment Practices, and Outcomes
Patterson, T. F., Kirkpatrick, W. R., White, M., Hiemenz, J. W., WINGARD, J. R., DUPONT, B., RINALDI, M. G., STEVENS, D. A., & Graybill, J. R. (2000) · Medicine · doi:10.1097/00005792-200007000-00006 · Cited by 791 · cited 1×
“Invasive aspergillosis in immunocompromised patients is often associated with poor therapeutic outcome (20).”
BackgroundPfaller, M. A., Sheehan, D. J., & Rex, J. H. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.2.268-280.2004 · Cited by 352 · cited 8×
“Successful treatment of invasive aspergillosis in immunocompromised patients may require fungicidal therapy, which will ultimately achieve eradication of the organism and clinical cure (21).”
BackgroundMethodInfluentialEspinel-Ingroff, A. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.3.954-958.2001 · Cited by 296 · cited 2×
“flavus by culture-based techniques (3, 5, 6, 11), flow cytometry (22), or time-kill assays (13, 25).”
BackgroundSutton, D. A., Sanche, S. E., Revankar, S. G., Fothergill, A. W., & Rinaldi, M. G. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.7.2343-2345.1999 · Cited by 255 · cited 2×
“terreus are concordant with previous findings (5, 24).”
BackgroundResultWalsh, T. J., Petraitis, V., Petraitiene, R., Field‐Ridley, A., Sutton, D., Ghannoum, M., Sein, T., Schaufele, R., Peter, J., Bacher, J., et al. (2003) · The Journal of Infectious Diseases · doi:10.1086/377210 · Cited by 253 · cited 3×
“fumigatus (16) 91 (88, 94) 91 (88, 94) 100 (100, 100) 22 (18, 25) 97 (94, 100) 100 (100, 100) A.”
BackgroundSelf-citationIn-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi
Johnson, E. M., Szekely, A., & Warnock, D. W. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/42.6.741 · Cited by 215 · cited 3×
“25 to 4 mg/liter, implying that voriconazole is fungicidal against these Aspergillus species (5, 11, 27).”
BackgroundEspinel-Ingroff, A., Fothergill, A., Peter, J., Rinaldi, M. G., & Walsh, T. J. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.9.3204-3208.2002 · Cited by 203 · cited 4×
“These MICs for Aspergillus isolates are similar to previously published MICs where pure powders of voriconazole and amphotericin B were used (9).”
BackgroundMethodResultInfluentialSelf-citationOrganism-Dependent Fungicidal Activities of Azoles
Manavathu, E. K., Cutright, J. L., & Chandrasekar, P. H. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.11.3018 · Cited by 190 · cited 4×
“terreus (13) 86 (83, 90) 91 (83, 100) 100 (100, 100) 68 (61, 75) 92 (85, 100) 100 (100, 100)”
BackgroundResultInfluentialEspinel-Ingroff, A., Chaturvedi, V., Fothergill, A., & Rinaldi, M. G. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.10.3776-3781.2002 · Cited by 167 · cited 3×
“After MIC determination, the MFCs of amphotericin B and voriconazole were determined from two duplicate microtitration plates by a conventional culture-based method (7, 9) and the new microbroth colorimetric method as follows.”
BackgroundMethodColorimetric Assay for Antifungal Susceptibility Testing of Aspergillus Species
Meletiadis, J., Mouton, J. W., Meis, J. F. G. M., Bouman, B. A., Donnelly, J. P., Verweij, P. E., & EUROFUNG Network (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.9.3402-3408.2001 · Cited by 161 · cited 2×
“Finally, growth was detected with an XTT [2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2Htetrazolium-5-carboxanilide] colorimetric assay (14).”
MethodSelf-citationMurphy, M., Bernard, E. M., Ishimaru, T., & Armstrong, D. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.3.696 · Cited by 151 · cited 1×
“fumigatus (2, 4, 10, 12, 17) in immunocompromised animals improved survival and reduced the fungal burden but never eradicated the organisms from all animals, even at high dosages (40 mg/kg of body weight).”
BackgroundClemons, K. V., Espiritu, M., Parmar, R., & Stevens, D. A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.12.4867-4875.2005 · Cited by 149 · cited 1×
“fumigatus (2, 4, 10, 12, 17) in immunocompromised animals improved survival and reduced the fungal burden but never eradicated the organisms from all animals, even at high dosages (40 mg/kg of body weight).”
BackgroundOdds, F. C., Van Gerven, F., Espinel-Ingroff, A., Bartlett, M. S., Ghannoum, M. A., Lancaster, M. V., Pfaller, M. A., Rex, J. H., Rinaldi, M. G., & Walsh, T. J. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.2.282 · Cited by 147
Self-citationIn Vitro Efficacy and Fungicidal Activity of Voriconazole against Aspergillus and Fusarium Species
Clancy, C. J., & Nguyen, M. H. (1998) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01708622 · Cited by 117 · cited 1×
“flavus by culture-based techniques (3, 5, 6, 11), flow cytometry (22), or time-kill assays (13, 25).”
BackgroundEspinel-Ingroff, A., Fothergill, A., Ghannoum, M., Manavathu, E., Ostrosky-Zeichner, L., Pfaller, M., Rinaldi, M., Schell, W., & Walsh, T. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.10.5243-5246.2005 · Cited by 101 · cited 1×
“terreus ATCC MYA-3633 were used as quality controls (8).”
MethodSelf-citationWarn, P. A., Sharp, A., & Denning, D. W. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki399 · Cited by 93 · cited 1×
“25 to 4 mg/liter, implying that voriconazole is fungicidal against these Aspergillus species (5, 11, 27).”
BackgroundGeorge, D., Miniter, P., & Andriole, V. T. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.1.86 · Cited by 92 · cited 1×
“fumigatus (2, 4, 10, 12, 17) in immunocompromised animals improved survival and reduced the fungal burden but never eradicated the organisms from all animals, even at high dosages (40 mg/kg of body weight).”
BackgroundEfficacy of Voriconazole in a Guinea Pig Model of Disseminated Invasive Aspergillosis
Kirkpatrick, W. R., McAtee, R. K., Fothergill, A. W., Rinaldi, M. G., & Patterson, T. F. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.10.2865-2868.2000 · Cited by 80 · cited 1×
“fumigatus (2, 4, 10, 12, 17) in immunocompromised animals improved survival and reduced the fungal burden but never eradicated the organisms from all animals, even at high dosages (40 mg/kg of body weight).”
BackgroundRodriguez-Tudela, J. L., Chryssanthou, E., Petrikkou, E., Mosquera, J., Denning, D. W., & Cuenca-Estrella, M. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.11.5236-5237.2003 · Cited by 79
Warn, P. A. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg185 · Cited by 68 · cited 1×
“terreus appear to be correlated with the MBX MFCs described here (19, 25, 26).”
BackgroundEfficacy of voriconazole against invasive pulmonary aspergillosis in a guinea-pig model
Chandrasekar, P. H. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/45.5.673 · Cited by 55 · cited 1×
“fumigatus (2, 4, 10, 12, 17) in immunocompromised animals improved survival and reduced the fungal burden but never eradicated the organisms from all animals, even at high dosages (40 mg/kg of body weight).”
BackgroundEspinel-Ingroff, A. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.605-607.2001 · Cited by 42 · cited 4×
“25 to 4 mg/liter, implying that voriconazole is fungicidal against these Aspergillus species (5, 11, 27).”
BackgroundResultInfluentialAntachopoulos, C., Meletiadis, J., Sein, T., Roilides, E., & Walsh, T. J. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl488 · Cited by 30 · cited 4×
“flavus (3%) isolates at high concentrations of amphotericin B, indicating differential amphotericin B activities against Aspergillus species, similar to that observed in the present study (1).”
BackgroundMethodInfluentialSelf-citationRamani, R., Gangwar, M., & Chaturvedi, V. P. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.11.3627-3629.2003 · Cited by 28 · cited 2×
“fumigatus conidia at 1 to 8 mg/liter of voriconazole after 48 h of incubation (22).”
Background
Research works printed but not linked: 1
- Motulsky, H. 2003. Prism 4 statistics guide-statistical analyses for laboratory and clinical researchers, p. 122-126. GraphPad Software Inc., San Diego, CA.
Cited by
Aspergillus fumigatus and Aspergillosis in 2019
Latgé, J.-P., & Chamilos, G. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00140-18 · Cited by 1,400
Antifungal Drug Development: Challenges, Unmet Clinical Needs, and New Approaches
Roemer, T., & Krysan, D. J. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019703 · Cited by 593
“Azoles inhibit ergosterol biosynthesis and, in general, are fungistatic; an important exception is that voriconazole is fungicidal toward A. fumigatus (Meletiadis et al. 2007).”
BackgroundMolecular Evolution of Antifungal Drug Resistance
Robbins, N., Caplan, T., & Cowen, L. E. (2017) · Annual Review of Microbiology · doi:10.1146/annurev-micro-030117-020345 · Cited by 441
Houšť, J., Spížek, J., & Havlíček, V. (2020) · Metabolites · doi:10.3390/metabo10030106 · Cited by 254
Qin, Y., Li, P., & Guo, Z. (2020) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2020.116002 · Cited by 196
Metadata
- Authors
- Meletiadis, J., Antachopoulos, C., Stergiopoulou, T., Pournaras, S., Roilides, E., & Walsh, T. J.
- Affiliations
- National Cancer Institute (US)
- University of Thessaly (GR)
- Aristotle University of Thessaloniki (GR)
- ORCID
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2007-09
- Volume
- 51
- Issue
- 9
- Pages
- 3329-3337
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC2043246
- OpenAlex
- W2138700722
- Cited by
- 100
- References
- 26
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 7 · 2023: 7 · 2022: 5 · 2021: 4 · 2020: 14 · 2019: 10 · 2018: 4 · 2017: 5 · 2016: 6 · 2015: 2 · 2014: 3 · 2013: 5 · 2012: 2
- FWCI
- 2.32
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- ORBi (University of Liège) (submittedVersion, other-oa)
- University of Thessaly Institutional Repository (University of Thessaly) (submittedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
- Keywords
- amphotericin B, voriconazole, Aspergillus fumigatus, Aspergillus flavus, Aspergillus terreus, fungicidal activity, minimum fungicidal concentration, antifungal susceptibility testing
- MeSH terms
- Amphotericin B, Antifungal Agents, Aspergillus, Colorimetry, Culture Media, Microbial Sensitivity Tests, Pyrimidines, Quality Control, Regression Analysis, Species Specificity, Spores, Fungal, Tetrazolium Salts, Triazoles, Colony Count, Microbial, Reproducibility of Results, Vitamin K 3, Voriconazole
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.